Navigation Links
Bradmer sponsors physician panel to raise awareness of brain cancer treatments
Date:11/5/2008

d tumors, GBM tumors do not metastasize, but cause symptoms and often death through invasion of nearby tissues and impairment of brain function. The current standard of care, consisting of surgery, radiation and adjuvant chemotherapy (temozolomide), extended average overall patient survival from 53 to 64 weeks.

About the GLASS-ART Trial(TM) (http://www.glassarttrial.com)

The Phase III GLASS-ART Trial derives its name from its description: GBM Locoregional Agent Survival Study - Antitenascin Radiolabeled antibody Therapy Trial. The study is designed to determine the survival benefit derived from, and safety of, adding Neuradiab to the current standard of care therapy for patients diagnosed with primary glioblastoma multiforme. The randomized trial will enroll up to 760 patients at leading treatment centers across the United States. Additional information on the trial can be found at http://www.glassarttrial.com or at http://www.clinicaltrials.gov and then by searching the term "Bradmer" or the study identifier NCT00615186.

About Neuradiab(TM)

Neuradiab is a monoclonal antibody, conjugated to radioactive iodine, used to treat glioblastoma multiforme (GBM), the most common and most advanced form of brain cancer. Neuradiab delivers tumor-killing radiation specifically to residual brain tumor cells after surgery, with minimal impact on normal brain tissue. During the course of development at Duke University, over US$60 million in research grants and related support has produced a series of Phase I and Phase II clinical trials on Neuradiab and other closely related technologies. Approximately 200 brain cancer patients, including over 160 with GBM, have been treated with the Neuradiab therapy regimen, and survival benefits have significantly exceeded historical controls in eac
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
2. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
3. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
4. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
5. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
6. Baxa Announces Colorado BioScience Association Sponsorship
7. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
8. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
9. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
10. iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers
11. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 25, 2014 Miles Holder, ... joined the Graphel Carbon Products team as Sales/Marketing Manager. ... marketing, and customer service for the graphite industry. , ... to our team,” stated Dave Trinkley, VP of Market ... wide range of experience in the graphite industry, along ...
(Date:11/26/2014)... 2014 Theravalues Corporation est fier d,annoncer ... européen au salon Hi Europe 2014 (du 2 ... Curcumine la plus biodisponible actuellement sur ... à des ingrédients approuvés par les règlements européens. ... présent dans la racine de curcuma ( Curcuma ...
(Date:11/24/2014)... Nov. 24, 2014  IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has submitted ... U.S. Food and Drug Administration (FDA), which brings the ... seven, with eighteen submissions now pending at the FDA. ... CEO of the Company, commented, "Our team here at ...
(Date:11/24/2014)... , November 24, 2014   ... online on ScienceDirect   Elsevier , a ... services, is pleased to announce the launch of the latest ... Current Opinion in Food Science . ... will provide specialists with a new platform to keep up-to-date ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3IGI Laboratories, Inc. Announces ANDA Submission 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... Information technology professionals might know technology, but business executives ... the Fusion 2005 CEO-CIO Symposium said as they ... ways a chief information officer can hold sway in the ... into decision making, said John Byrnes, managing director of the ...
... investment, but with a good ROI strategy it doesn't have ... a tangible and timely return on investment (ROI). Your company's ... accountable members of its marketing team. Accountability is a good ... , ,ROI objectives can represent tangible things such as cost ...
... of tracking U.S. biotech financing in all its shapes and forms ... and Big Pharma). From its recent analysis, it would appear that ... the financing categories. Lets take a look: , , ... into the biotech sector from a variety of different sources, 2004 ...
Cached Biology Technology:CIOs learn boardroom-speak 2CIOs learn boardroom-speak 3How hard is your Web site working? 2How hard is your Web site working? 3How hard is your Web site working? 42004 a banner year for biotech financing 2
(Date:11/18/2014)... Nov. 18, 2014   EyeLock Inc. , ... and MorphoTrust USA (Safran), a leading ... announced a strategic partnership to offer comprehensive biometric ... administration (MVA), airport screening and financial services markets. ... MorphoTrust serves consumers through a nationwide network of ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/6/2014)... Except when that predator runs so fast that it essentially ... is the fastest creature on Earth. Some of these half-inch-long ... five miles per hour). The fastest human can do about ... tiger beetle, a person would have to hit 480 miles ... At peak speeds, everything becomes a blur. They can,t gather ...
Breaking Biology News(10 mins):EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3The tiger beetle: Too fast to see 2
... Twenty environmental researchers from across North America have ... Based at Stanford University,s Woods Institute for ... in 1998 to help academic scientists make their ... the program selects up to 20 mid-career academic ...
... all holders of a valid press card / formal ... press facilities, including a working room and an interview ... to assist you in organising interviews with relevant experts. ... online at: http://www.eular.org/congress_press_registration.cfm , Please direct any ...
... Two Washington University in St. Louis scientists are imitating nature ... problems in orthopedic surgery: reattaching tendon to bone. Their ... repairs. The rotator cuff is the group of four tendons ... injured, the tendons tear or detach from the bone. ...
Cached Biology News:20 researchers selected as 2011 Leopold Leadership Fellows 220 researchers selected as 2011 Leopold Leadership Fellows 320 researchers selected as 2011 Leopold Leadership Fellows 4Biomimetic patch to be tested on tricky tendon-to-bone repairs 2Biomimetic patch to be tested on tricky tendon-to-bone repairs 3Biomimetic patch to be tested on tricky tendon-to-bone repairs 4
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...
... need to perform time consuming and inaccurate comparison ... any found variants of the sample when compared ... our mutation electropherogram as a sharp peak. ... mode is over 99%, with sensitivity to greater ...
Biology Products: